Ken Fisher Synthetic Biologics, Inc. Transaction History

Fisher Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	SELL	$4.6 - $7.2 $9,200 - $14,400	-2,000 Reduced 1.57%	125,698 $76,000
Q1 2021 Apr 27, 2021	BUY	$5.0 - $11.7 $10,000 - $23,400	2,000 Added 1.59%	127,698 $87,000
Q4 2020 Jan 29, 2021	BUY	$2.9 - $4.6 $189,573 - $300,702	65,370 Added 108.36%	125,698 $48,000
Q2 2020 Aug 07, 2020	BUY	$2.8 - $5.7 $168,918 - $343,869	60,328 New	60,328 $31,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.